Web Date: November 5, 2009
An Enzyme Reveals An Unexpected Inclusiveness
European researchers have discovered the first enzyme that can simultaneously bind both enantiomers of a chiral molecule in its active site. They believe this behavior could have important implications for drug discovery.
Usually, an enzyme can bind only one enantiomer of a chiral molecule. Rare cases have previously been discovered in which a second enantiomer can also bind to an enzyme's active site, but never at the same time as the first. Now, in work . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society